Holdings
Regeneron Pharmaceuticals, Inc.
As of Jun 30, 2026, Regeneron Pharmaceuticals, Inc. reported 3 positions worth US$177M. Largest: Parabilis Medicines, Inc., Intellia Therapeutics, Inc. and Adicet Bio, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Parabilis Medicines, Inc. | 4.17M | US$114M | new | Jun 30, 2026 |
| Intellia Therapeutics, Inc. | 3.7M | US$62.7M | no change | Jun 30, 2026 |
| Adicet Bio, Inc. | 60,511 | US$523K | new | Jun 30, 2026 |